Investors and patients will have to wait sometime for such products to launch, however, with Zealand Pharma's CEO and President Adam Steensberg telling CNBC that he expects Petrelintide to come to market around 2030
Starchy Carbohydrates & Fat Loss, Ketogenic Diet 01:10:36 Inflammation, Fat & Macronutrients, Hyper-Palatability
Enrichment of gut-derived metabolites in a Parkinsons disease subtype with REM sleep behavior disorder
Quality of life and symptom intensity over time in people with cancer receiving palliative care: results from the international European palliative care cancer symptom study
Mikus D, Sikiric P, Seiwerth S, Petricevic A, Aralica G, Druzijancic N, et al